NEWS IFPI EN

Global challenges call for global solutions: the 3rd International Forum of Pharmaceutical Inspectorates has started in Hanoi

Global challenges call for global solutions: the 3rd International Forum of Pharmaceutical Inspectorates has started in Hanoi

HANOI, Vietnam – November 16, 2026

The 3rd International Forum of Pharmaceutical Inspectorates (IFPI) opened today in the capital of Vietnam. Leading regulators, representatives of international organizations and industry experts from more than 40 countries have come together to identify real and concrete ways to address the challenges facing global pharmaceutical regulation today.

Building reliance through ongoing cooperation

Because global challenges require global solutions, only a coordinated approach can deliver meaningful results. According to the Forum’s organizers, the level of regulatory reliance and mutual recognition discussed at various platforms for decades, cannot be achieved without continuous and close cooperation.

Routine daily information exchange, along with a readiness to share expertise and inspection findings, are becoming the new standard of work. This is why IFPI serves as a key platform for connecting national regulatory systems and harmonizing regulatory requirements. Participants are working together on solutions that can make the global system of medicines regulation more transparent and reliable.

The Plenary session sets the strategic direction

The Forum began with a Plenary session titled “Good Regulatory Practice: Harmonizing and Strengthening Medicines Regulatory Systems.” The discussion brought together heads of national regulatory authorities and leading pharmaceutical experts. Key players in pharma industry focused on strategic questions: how to transform dialogue into effective mutual recognition mechanisms, overcome regulatory barriers, streamline processes, and ensure patients have uninterrupted access to innovative therapies.

Vladislav Shestakov, Chairman of the IFPI Steering Committee: “Differences in fundamental requirements, standards and approaches, and the absence of common rules and procedures are counterproductive in today’s environment. This can become a serious barrier to providing the population with quality medicines. We see that open cooperation between regulatory authorities of different countries helps to reduce these differences. And our Forum is an exceptionally effective platform for developing coordinated professional responses to modern challenges in ensuring the quality, efficacy and safety of medicines.”

Dr. Ta Manh Hung, Deputy Director General of the Drug Administration of Vietnam (DAV): “Today, pharmaceutical supply chains operate globally, and no single inspectorate can oversee everything on its own. IFPI gathers leading inspectors and regulators from different regions in one room for open, peer-to-peer discussions. It is this direct dialogue that turns written GMP rules into consistent global practice and makes genuine regulatory reliance possible.”

From theory to practice: focus on real tools

The main agenda addresses how to apply Good Regulatory Practice (GRP) principles, make inspections more effective, strengthen mutual reliance mechanisms among regulators, and adopt modern approaches to manufacturing and quality control for advance therapy medicinal products.

“Bringing together GMP and Good Regulatory Practice (GRP) has now become extremely important. While GMP ensures medicines are produced to high quality standards, a regulatory system that is slow, redundant, or unpredictable still leaves patients waiting too long for essential and innovative treatments. Combining GMP and GRP is a move toward smarter regulation: using transparent timelines, risk-based inspections, and regulatory reliance, while at the same time creating conditions for the effective provision of safe, quality medicines to patients,” notes Dr. Ta Manh Hung, Deputy Director General of the Drug Administration of Vietnam (DAV).

The second day of the Forum will be practice-oriented, concentrating on how to make GMP inspections more effective and how to strengthen inspectors’ professional competencies.

Participants will focus on:

· Current regulatory approaches for cell therapies, blood products, and radiopharmaceuticals;

· Improving professional competencies and practical tools for enhancing the effectiveness of regulatory systems during closed regulator-only sessions;

· Applying risk-based approaches and further development of joint training GMP inspections through IFPI working groups;

· Harmonizing Good Manufacturing Practice standards to reduce regulatory barriers in international trade, exchange of experience, and expanding cooperation.

About the International Forum of Pharmaceutical Inspectorates (IFPI)

IFPI is a major global platform for professional exchange aimed at protecting patients worldwide. The Forum strengthens international regulatory collaboration, promotes the harmonization of medicine quality standards, and creates conditions for the introduction of best inspection practices. The 2026 edition is taking place in Hanoi (Vietnam) on November 16–17.
2026-11-17 14:42